The strong disapproval of the South African government’s handling of the pandemic is a warning that crafting persuasive pro-vaccine messages is not enough.
L’expertise universitaire, l’exigence journalistique
Articles sur COVID-19
Affichage de 2401 à 2420 de 7970 articles
Relying on donor funding means that the funder ultimately determines the health priorities. This is one reason why many programmes in Africa focus on a single disease such as HIV.
CC BY-NC-ND10,1 Mo (download)
The COVID-19 resurgence in South Africa is likely to take a heavy toll. It is important for vaccination efforts to be ramped up.
Worries about the potential repercussions of providing legal and accurate abortion care are endangering people’s health and lives
Athletes headed to Tokyo have trained throughout an unusually stressful year. Missing out on final preparations could hinder their chances at a medal
A study at the University of Oxford has looked at what happens when people receive one dose of AstraZeneca one dose of Pfizer.
A society in crisis is more than the sum of its flawed parts.
Data from the UK, where the Delta variant is dominant, suggest many people with COVID-19 are experiencing cold-like symptoms such as a runny nose and a sore throat.
More than two-thirds of requests to go to the UK were approved, compared to just 46% for trips to India and 59% to China.
With enough vaccine supplies coming online from October, the government has no excuse not to have all arrangements in place for an efficient vaccination program. Here’s what needs to change.
Our modelling shows the elimination strategy, including early, sharp lockdowns, remains Australia’s best policy.
At the height of polio and H1N1, Canadians were keen to get vaccinated, but vaccine enthusiasm waned once the crisis had passed — what does that mean for COVID-19?
When a crisis like COVID-19 disrupts expectations for the future, it also disrupts how health messaging works. Advertising research shows three ways that health campaigns can succeed in a crisis.
The plight of women who had to give birth alone during the pandemic is a good starting point to discuss a better childbirth experience for all women.
Should people be compelled to take the vaccine? Should you feel guilty for skipping the line? And what about parts of the world where vaccines aren’t readably available? Ethicists have it covered.
New Zealand will have to vaccinate 80-85% to reach population immunity. Until then, a blanket border re-opening, even if only for vaccinated people, would pose a high risk of new outbreaks.
Pressure is mounting to reopen the Canada-U.S. border, but there are risks. How well those risks are managed may be the difference between pandemic recovery or a fourth wave of COVID-19.
Despite fake news commonly being cited as a danger to society, very little research has been conducted on its ability to alter what people think.
While Pfizer is still the preferred vaccine for under 40s, those who don’t want to wait can now talk to their GP about getting an AstraZeneca shot. But what risks and benefits do you need to weigh up?
The federal government has announced COVID-19 vaccination will now become mandatory for aged-care workers. This comes amid a slow and troubled rollout in the sector.
Les contributeurs les plus fréquents
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Senior Research Fellow in Global Health, University of Southampton
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Medicine, University of East Anglia
-
Associate Professor, School of Population Health, UNSW Sydney
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Public Health, University of Sheffield
-
Professor of Medicine, University of Virginia
